Close Menu

Quanta BioSciences

The company provided updates on its newborn screening testing presence.

The company is developing dedicated product lines for next-generation sequencing that incorporate a thermal cycler capable of 35-minute PCR.

NEW YORK (GenomeWeb) ― Tracking immunity and virus shedding after oral polio vaccination usually requires culture of poliovirus from stool samples.

NEW YORK (GenomeWeb) – An international team of academic and industry researchers this week published the results of a comparison of commercially available platforms for microRNA expression analysis, finding that each has its own strengths and shortcomings that should be considered before selecti

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has given 510(k) clearance to the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel.

The University of Washington has been awarded US Patent No. 8,420,325, "Thermostable polymerases having altered fidelity and methods of identifying and using same."
Lawrence Loeb, Leroy Hood, and Motoshi Suzuki are named as inventors.

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

Corbett Life Science has been awarded US Patent No. 8,124,413, "Thermocycler and sample port."
Keith Stanley and John Corbett are named as inventors on the patent.

Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

A US district court has dismissed a lawsuit filed earlier this year against more than a dozen life science companies alleging that they falsely marked certain nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.